Early Detection of Wildlife Disease Pathogens Using CRISPR-Cas System Methods

Area of Science:

• Veterinary Medicine
• Molecular Diagnostics
• Wildlife Health

Background:

• Wildlife diseases pose significant risks to human health, conservation efforts, and economic stability.
• Effective surveillance is essential for mitigating the impact of animal diseases.
• CRISPR-Cas biosensors are advanced diagnostic tools for detecting pathogen DNA/RNA in human disease monitoring.

Purpose of the Study:

• To explore the potential of CRISPR-Cas biosensor technology for wildlife disease monitoring.
• To identify how this technology can be better leveraged for advancing wildlife health surveillance.
• To emphasize the need for standardized protocols to ensure data reliability in wildlife disease management.

Main Methods:

• Review of current CRISPR-Cas biosensor applications and their potential for wildlife disease surveillance.
• Analysis of the technical, operational, and cost requirements for end-user application in wildlife settings.
• Exploration of strategies for protocol standardization to enhance data reliability.

Main Results:

• CRISPR-Cas biosensors show promise for rapid, cost-effective wildlife disease surveys.
• Current application of these biosensors in wildlife disease management lags behind human disease applications.
• Standardization of protocols is identified as a critical factor for successful implementation.

Conclusions:

• CRISPR-Cas biosensors represent a significant opportunity to enhance wildlife disease monitoring capabilities.
• Further development and standardization are needed to fully realize the potential of these tools in wildlife health.
• Adoption of standardized protocols will ensure reliable and effective wildlife disease surveillance.